[
  {
    "ts": null,
    "headline": "PFE or LLY: Which Is the Better Value Stock Right Now?",
    "summary": "PFE vs. LLY: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=d02ea02130a076be67252f2130b2af49278d156e83ac6668b6824732440626c3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750088404,
      "headline": "PFE or LLY: Which Is the Better Value Stock Right Now?",
      "id": 135313683,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "PFE vs. LLY: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=d02ea02130a076be67252f2130b2af49278d156e83ac6668b6824732440626c3"
    }
  },
  {
    "ts": null,
    "headline": "EMA Accepts GSK's Filing for Expanded Use of RSV Vaccine Arexvy",
    "summary": "GSK's regulatory filing for expanded use of RSV vaccine, Arexvy, in adults aged 18 years and older has been accepted for review by the EMA.",
    "url": "https://finnhub.io/api/news?id=f2d5491c35472fba2381f65a433394914074e25f39bebbdbf2f157a10b30839e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750087200,
      "headline": "EMA Accepts GSK's Filing for Expanded Use of RSV Vaccine Arexvy",
      "id": 135318002,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "GSK's regulatory filing for expanded use of RSV vaccine, Arexvy, in adults aged 18 years and older has been accepted for review by the EMA.",
      "url": "https://finnhub.io/api/news?id=f2d5491c35472fba2381f65a433394914074e25f39bebbdbf2f157a10b30839e"
    }
  },
  {
    "ts": null,
    "headline": "4 Value Stocks to Shield Your Portfolio Amid Geopolitical Turmoil",
    "summary": "As geopolitical risks jolt markets, STNE, CNC, CVS and PFE shine with low cash flow valuations and solid earnings outlooks.",
    "url": "https://finnhub.io/api/news?id=0717c8198ebe24cb9b04470a0234505e8faaaae89aa7696a58d49487a904b92f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750080540,
      "headline": "4 Value Stocks to Shield Your Portfolio Amid Geopolitical Turmoil",
      "id": 135309586,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "As geopolitical risks jolt markets, STNE, CNC, CVS and PFE shine with low cash flow valuations and solid earnings outlooks.",
      "url": "https://finnhub.io/api/news?id=0717c8198ebe24cb9b04470a0234505e8faaaae89aa7696a58d49487a904b92f"
    }
  },
  {
    "ts": null,
    "headline": "5 Large Drug Stocks That Are Poised to Ride on Sector Recovery",
    "summary": "In the Large-Cap Pharmaceuticals industry, AbbVie, Novartis, Pfizer, Sanofi and Bayer are worth retaining amid macro pressure and rising innovation.",
    "url": "https://finnhub.io/api/news?id=654dcc3ef1c2a828a9daf3effc8177dfd9f1b913b552cd45be3e62a40029cd71",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750079160,
      "headline": "5 Large Drug Stocks That Are Poised to Ride on Sector Recovery",
      "id": 135305468,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "In the Large-Cap Pharmaceuticals industry, AbbVie, Novartis, Pfizer, Sanofi and Bayer are worth retaining amid macro pressure and rising innovation.",
      "url": "https://finnhub.io/api/news?id=654dcc3ef1c2a828a9daf3effc8177dfd9f1b913b552cd45be3e62a40029cd71"
    }
  },
  {
    "ts": null,
    "headline": "Can J&J's Innovative Medicines Unit Sustain Growth Amid Stelara LOE?",
    "summary": "JNJ's Innovative Medicines unit shows a growth trend, defying Stelara LOE and the negative impact of the Part D redesign.",
    "url": "https://finnhub.io/api/news?id=5f33d906adc1b592893ec7877c438cb630f84195085347af1aa3d983c53d2697",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750078800,
      "headline": "Can J&J's Innovative Medicines Unit Sustain Growth Amid Stelara LOE?",
      "id": 135314386,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "JNJ's Innovative Medicines unit shows a growth trend, defying Stelara LOE and the negative impact of the Part D redesign.",
      "url": "https://finnhub.io/api/news?id=5f33d906adc1b592893ec7877c438cb630f84195085347af1aa3d983c53d2697"
    }
  },
  {
    "ts": null,
    "headline": "1 S&P 500 Stock to Keep an Eye On and 2 to Steer Clear Of",
    "summary": "The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.",
    "url": "https://finnhub.io/api/news?id=e691b86f680c39aa6d131c2af9565ded8149fa27efdd512e0b660c606ae2fb19",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750048566,
      "headline": "1 S&P 500 Stock to Keep an Eye On and 2 to Steer Clear Of",
      "id": 135301235,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.",
      "url": "https://finnhub.io/api/news?id=e691b86f680c39aa6d131c2af9565ded8149fa27efdd512e0b660c606ae2fb19"
    }
  }
]